1. HHS and the U.S. Department of Defense said Feb. 11 they purchased an additional 100 million COVID-19 vaccine doses from both Pfizer and Moderna.
2. The FDA said Moderna could put 14 doses of the COVID-19 vaccine into its vials, according to a Feb. 12 report. Previously, only 10 doses were approved per vial.
3. AstraZeneca set a monthly production goal of 200 million COVID-19 vaccine doses, doubling its current manufacturing output, according to a Feb. 11 earnings call.
4. CVS and Walgreens are vaccinating employees with leftover COVID-19 doses to prevent waste. Read how other retail pharmacies are handling extra doses here.
5. Drugmaker Sanofi’s COVID-19 vaccine candidate won’t be finished in 2021. The vaccine may be used at a later stage if the fight against variants continues, CEO Paul Hudson told The Hill in a Feb. 13 report.
More articles on surgery centers:
12-OR ASC part of $295M Florida orthopedic hospital expansion
3 ASCs launching total joint programs
4 ASCs installing total joint robots
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
